Andrea Anderson

Contributor

Phone Number

+1-780-990-0086

Email

Andrea Anderson covers genomics research studies and translational research for GenomeWeb. Find her on Twitter at @andyandy_tk.

Articles Authored by Andrea Anderson

Sep 22, 2020

Metastatic Cancer Treatment Markers Identified in Clinical WGS Study

Interim results from a study in the Netherlands suggest whole-genome sequencing can be done fast enough to uncover treatment targets in metastatic cancer patients.

Sep 20, 2020

HPV, p16 May Offer Different Prognostic Clues in Oropharyngeal Cancer, ESMO Data Reveals

Premium

Patients with discordant p16 and HPV markers fall into an intermediate risk group, research presented at the European cancer conference suggests.

May 31, 2020

Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers

Breast cancer risk in carriers of pathogenic CHEK2 variants may be classified as low, moderate, or high by adding in polygenic risk score and family history data.

May 05, 2020

Invitae Study Finds Germline Risk Variants in Wide Range of Prostate Cancer Patients

Data presented at ACMG's online annual meeting suggests that more than 10 percent of prostate cancer patients across disease stages carry inherited cancer-related variants.

Apr 29, 2020

Normal Breast Cell Types, States Characterized by Single-Cell Transcriptome Analysis

A single-cell "atlas" of pathologically normal breast tissue was presented by an MD Anderson Cancer Center representative at the AACR's online annual meeting this week.

Apr 20, 2020

Teams Scour ACE2 Sequence, Expression Data to Search For SARS-CoV-2 Infection Clues

By tapping into available population sequence and single-cell RNA sequence data, researchers are attempting to understand SARS-CoV-2 susceptibility.

Apr 13, 2020

SARS-CoV-2 Genomes Let Researchers Retrace Viral Spread, Mitigation Effects

Researchers have been using Nextstrain, which includes data for thousands of SARS-CoV-2 genomes, to study how the virus accrues mutations over time.

Apr 08, 2020

23andMe to Study Genetic Factors of COVID-19 Severity Using Data From Consented Customers

Drawing from its massive consumer genetic dataset and longitudinal survey data, 23andMe is searching for genetic features that might influence the severity of SARS-CoV-2 infections.

Mar 26, 2020

COVID-19 Host Susceptibility Studies Ramp Up Internationally

Investigators worldwide are sharing data to search for features in the human genome that might contribute to COVID-19 susceptibility or progression.

Mar 06, 2020

CHOP Shares Insights, Experience From Centralized Genomic Medicine Lab

Premium

Nearly 3,500 patients were referred to the Roberts Individualized Medical Genetics Center for exome sequencing or other testing during the clinical program's first four years.

Breaking News

The Scan

Stricter Vaccine Standards

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

Another Trial to Ramp Up

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Few Billion More

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

Genome Research Studies on SARS-CoV-2 Super-Spreaders, Pan-Cancer Epigenetics, More

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.

Menu